CN Patent

CN102844028B — Hcv大环抑制剂、非核苷和核苷的组合

Assigned to Medivir AB · Expires 2016-04-06 · 10y expired

What this patent protects

本发明涉及大环HCV蛋白酶抑制剂、大环非核苷HCV聚合酶抑制剂和核苷HCV聚合酶抑制剂的组合。

USPTO Abstract

本发明涉及大环HCV蛋白酶抑制剂、大环非核苷HCV聚合酶抑制剂和核苷HCV聚合酶抑制剂的组合。

Drugs covered by this patent

Patent Metadata

Patent number: CN102844028B
Jurisdiction: CN
Classification: —
Expires: 2016-04-06
Drug substance claim: No
Drug product claim: No
Assignee: Medivir AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.